2018 Volume 44 - Canada Communicable Disease Report (CCDR)
ISSN: 1481-8531
2018 Volume 44
CCDR: Volume 44-12, December 6, 2018: Adult immunization
- Investigation and management of a large community mumps outbreak among young adults in Toronto, Canada, January 2017–February 2018
- Outbreak of invasive Streptococcus pneumoniae among an inner-city population in Victoria, British Columbia, 2016–2017
- HIV in Canada—Surveillance Report, 2017
- Vaccine safety surveillance in Canada: reports to CAEFISS, 2017
- Evidence for optimal HIV screening and testing intervals in HIV-negative individuals from various risk groups: A systematic review
- What is new in the Canadian Immunization Guide: November 2016 to November 2018
- Correction for Can Commun Dis Rep 2018;44(11)
- Authors’ Correction: Can Commun Dis Rep 2018;44(9)
- Thank you to all the peer reviewers for CCDR in 2018
CCDR: Volume 44-11, November 1, 2018: Healthcare-associated infections and antimicrobial resistance
- Something wicked this way comes: What health care providers need to know about Candida auris
- Bringing home unwelcome souvenirs: Travel and drug‑resistant bacteria
- National Advisory Committee on Infection Prevention and Control in Canada: A new name for a longstanding group
- Tuberculosis drug resistance in Canada: 2017
- Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017
- CPHLN recommendations for the laboratory detection of Shiga toxin-producing Escherichia coli (O157 and non‑O157)
- Can Commun Dis Rep 2018;44(10)
CCDR: Volume 44-10, October 4, 2018: Climate change and Lyme diseases
- The continued rise of Lyme disease in Ontario, Canada: 2017
- Ixodes scapularis tick distribution and infection rates in Ottawa, Ontario, 2017
- A scoping review of Lyme disease research relevant for public health
- A scoping review of Lyme disease research relevant for public health – Supplementary References
- Results of a population screening intervention for tuberculosis in a Nunavik village, Quebec, 2015–2016
- Outbreak of Salmonella Chailey infections linked to precut coconut pieces — United States and Canada, 2017
- Advancing knowledge and increasing capacity to address climate-driven infectious diseases in Canada
- Correction for Can Commun Dis Rep Supplement 2018;44(9)
CCDR: Volume 44-9, September 6, 2018: Respiratory infections
- Clinical characteristics of pediatric pertussis cases, Quebec 2015–2017
- Should equivocal Bordetella pertussis PCR results in children be reported to public health?
- Influenza outbreaks in Ontario hospitals, 2012–2016
- Vaccine safety surveillance in Canada: Reports to CAEFISS, 2013–2016
- Rat bite fever on Vancouver Island: 2010–2016
- Summary of the NACI Update on Herpes Zoster Vaccines
- Updated NACI recommendations for measles post-exposure Prophylaxis
CCDR: Volume 44-7/8, July 5, 2018: Can we eliminate hepatitis C?
- Impact of availability of direct-acting antivirals for hepatitis C on Canadian hospitalization rates, 2012–2016
- Awareness and knowledge of hepatitis C among health care providers and the public: A scoping review
- Barriers to and facilitators of hepatitis C virus screening and testing: A scoping review
- Hepatitis C virus infection in Saskatchewan First Nations communities: Challenges and innovations
- A summary of the Pan-Canadian framework on sexually-transmitted and blood-borne infections
- Community outbreak of invasive group A streptococcus infection in Ontario, Canada
- Hep C in Canada 2018: infographic
CCDR: Volume 44-6, June 7, 2018: Vacine update
- Summary of the NACI Seasonal Influenza Vaccine Statement for 2018–2019
- Summary of the NACI literature review on the comparative effectiveness of subunit and split virus inactivated influenza vaccines in older adults
- Do health care providers trust product monograph information regarding use of vaccines in pregnancy? A qualitative study
- Pre-clinical development of a vaccine against Lassa fever
- Strategies for increasing uptake of vaccination in pregnancy in high-income countries: A systematic review
- Biological feasibility and importance of a gonorrhea vaccine for global public health
- First imported case of Mayaro virus detected in Canada
CCDR: Volume 44-5, May 3, 2018: Emergency Response
- Fifteen years post-SARS: Key milestones in Canada's public health emergency response
- An overview of the National Microbiology Laboratory emergency management program
- Canadian Pandemic Influenza Preparedness: Communications strategy
- Misidentification of Risk Group 3/Security Sensitive Biological Agents by MALDI-TOF MS in Canada: November 2015–October 2017
- Raccoon rabies outbreak in Hamilton, Ontario: A progress report
- CATMAT: Use of booster doses of yellow fever vaccine
- Update on CATMAT's evidence-based recommendations
CCDR: Volume 44-3/4, March 1, 2018: Can we eliminate Tuberculosis?
- Tuberculosis in Canada, 2016
- Tuberculosis in Canada: 2016 Supplementary Tables
- Addressing tuberculosis among Inuit in Canada, 2010-2015
- A cluster of tuberculosis cases linked to smoking: An under-recognized challenge for tuberculosis elimination
- Summary of the NACI Update on Immunization in Pregnancy with Tetanus Toxoid, Reduced Diphtheria Toxoid and Reduced Acellular Pertussis (Tdap) Vaccine
- Rapid testing for TB drug-susceptibility
- Rapid diagnostic testing for TB meningitis
- Can Commun Dis Rep. 2018;44(2)
- Can Commun Dis Rep 2017;43(12)
- Can Commun Dis Rep 2017;43(11)
- Can Commun Dis Rep 2017;43(3/4)
CCDR: Volume 44-2, February 1, 2018: Sexually transmitted infections
- Gonorrhea in Canada, 2010–2015
- Infectious and congenital syphilis in Canada, 2010–2015
- Chlamydia in Canada, 2010–2015
- Lymphogranuloma venereum in Quebec: Re-emergence among men who have sex with men
- Resources to address stigma related to sexuality, substance use and sexually transmitted and blood-borne infections
- Rolling out HIV antiretroviral therapy in sub-Saharan Africa: 2003–2017
- Outbreak of Seoul virus among rats and rat owners — United States and Canada, 2017
CCDR: Volume 44-1, January 4, 2018: Emergency planning
- Federal, provincial and territorial public health response plan for biological events
- Canadian Pandemic Influenza Preparedness: Health sector planning guidance
- Canada's Pandemic Influenza Preparedness: Laboratory strategy
- Canada's Pandemic Influenza Preparedness: Surveillance strategy
- Travel-related Zika virus cases in Canada: October 2015–June 2017
- Zika virus: Where to from here?
- Canadian recommendations for laboratory interpretation of multiple or extensive drug resistance in clinical isolates of Enterobacteriaceae, Acinetobacter species and Pseudomonas aeruginosa
- Human cases of West Nile virus in Canada, 2017
- Thank you to 2017 peer reviewers